Hauptseite > Publikationsdatenbank > Rho-kinase: regulation, (dys)function, and inhibition > print

001     140000
005     20210129212738.0
024 7 _ |a 10.1515/hsz-2013-0181
|2 doi
024 7 _ |a 1431-6730
|2 ISSN
024 7 _ |a 1437-4315
|2 ISSN
024 7 _ |a WOS:000325717100005
|2 WOS
024 7 _ |a 2128/18352
|2 Handle
037 _ _ |a FZJ-2013-05967
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Amin, Ehsan
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Rho-kinase: regulation, (dys)function, and inhibition
260 _ _ |a Berlin [u.a.]
|c 2013
|b de Gruyter
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1385650855_8463
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |3 POF3_Assignment on 2016-02-29
520 _ _ |a In a variety of normal and pathological cell types, Rho-kinases I and II (ROCKI/II) play a pivotal role in the organization of the nonmuscle and smooth muscle cytoskeleton and adhesion plaques as well as in the regulation of transcription factors. Thus, ROCKI/II activity regulates cellular contraction, motility, morphology, polarity, cell division, and gene expression. Emerging evidence suggests that dysregulation of the Rho-ROCK pathways at different stages is linked to cardiovascular, metabolic, and neurodegenerative diseases as well as cancer. This review focuses on the current status of understanding the multiple functions of Rho-ROCK signaling pathways and various modes of regulation of Rho-ROCK activity, thereby orchestrating a concerted functional response.
536 _ _ |a 452 - Structural Biology (POF2-452)
|0 G:(DE-HGF)POF2-452
|c POF2-452
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |a Dubey, Badri Nath
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Zhang, Si-Cai
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Gremer, Lothar
|0 P:(DE-Juel1)145165
|b 3
|u fzj
700 1 _ |a Dvorsky, Radovan
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Moll, Jens M.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Taha, Mohamed S.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Nagel-Steger, Luitgard
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Piekorz, Roland P.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Somlyo, Avril V.
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Ahmadian, Mohammad R.
|0 P:(DE-HGF)0
|b 10
|e Corresponding author
773 _ _ |a 10.1515/hsz-2013-0181
|g Vol. 394, no. 11
|0 PERI:(DE-600)1466062-3
|n 11
|p 1399-1410
|t Biological chemistry
|v 394
|y 2013
|x 1437-4315
856 4 _ |u http://www.degruyter.com/view/j/bchm.2013.394.issue-11/hsz-2013-0181/hsz-2013-0181.xml
856 4 _ |u https://juser.fz-juelich.de/record/140000/files/FZJ-2013-05967.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:140000
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)145165
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-559H
|2 G:(DE-HGF)POF3-500
|v Addenda
|x 0
913 1 _ |a DE-HGF
|b Schlüsseltechnologien
|1 G:(DE-HGF)POF2-450
|0 G:(DE-HGF)POF2-452
|2 G:(DE-HGF)POF2-400
|v Structural Biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l BioSoft
914 1 _ |y 2013
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21